Comprehensive Study Guide to Bovine Colibacillosis (Etiology, Pathogenesis, Clinical Forms, Diagnosis, and Management)

Overview and Definition of Colibacillosis

• General Definition: Colibacillosis (Romanian: Colibacilozele or Colibaciloza viței) encompasses acute infectious diseases caused by various serotypes of Escherichia coli, affecting virtually all domestic animal species.
• Pathological Variations: Morphoclinical manifestations differ widely depending on the incriminated pathotype (serotype) of E. coli and the specific susceptibility or resistance of the host.
• Clinical Triad in Calves: In newborn calves, colibacillosis manifests predominantly as an acute condition characterized clinically by:
  • General systemic disturbances (tulburări generale)
  • Severe dehydration (deshidratare)
  • Profuse, debilitating diarrhea (diaree gravă)

Etiological Characteristics of Escherichia coli

• Morphological and Staining Properties:
  • Gram-negative rod ($G^-$)
  • Pleomorphic / polymorphic (polimorfă)
  • Motile (mobilă)
  • Non-spore-forming (nesporulată)
• Envelope and Capsular Structure:
  • Strains possessing the "A" envelope antigen (antigenul de înveliș „A”) are classified as having a true anatomical capsule (capsulă adevărată).
  • The bacterial envelope consists of complex surface structures that mediate environmental survival and tissue adherence.

Antigenic Structure and Heterogeneity

Escherichia coli exhibits marked antigenic complexity, with distinct structural antigens driving colonization, serological classification, and host immune evasion:

• Somatic "O" Antigens (Antigenii „O” somatici):
  • Thermostable surface lipopolysaccharide antigens.
  • Present across all morphological forms.
  • A total of 173 serological "O" groups have been recognized.
• Flagellar "H" Antigens (Antigenii „H” flagelari):
  • Protein antigens located on the flagella of motile strains.
  • A total of 56 "H" antigens have been identified.
• Envelope / Capsular "K" Antigens (Antigenii „K” de înveliș):
  • Include the subcategories L, A, and B.
  • Responsible for mediating adherence in vivo and in vitro to the epithelial enterocytes of the small intestine.
  • A total of 103 "K" antigens have been documented.
• Mucous "M" Antigens (Antigenii „M”):
  • Composed of colanic acid (acidul colinic).
  • Responsible for producing the mucoid colony appearance observed in certain isolates.
• Rough "R" Antigens (Antigenele „R”):
  • Lipopolysaccharide structures that lack the specific O-polysaccharide side chains.
  • Rough ("R") mutants can arise spontaneously from smooth ("S") parental strains.
• Adhesins (Adezinele):
  • Antigenic colonization factors (factorii de colonizare antigenică) that project from the cell wall to mediate initial mucosal anchorage.

Serogroups Associated with Calf Pathology

Specific E. coli serogroups possess high clinical and epizootiological significance in bovine pathology, particularly O8, O15, O115, and O78:

• Colisepticemia (Colisepticemie):
  • Serogroups O78 and O115.
• Enteric Form (Forma enterică):
  • Serogroups O8, O101, O141, and O147.
• Colibacillary Enterotoxemia (Enterotoxiemie colibacilară):
  • Serogroup O101.

Virulence and Toxicity Factors

Pathogenesis relies on distinct virulence determinants and elaborated toxic substances:

• Virulence Factors (Factori de virulență):
  • Adhesins or adherence factors (adezinele sau factorii de aderență), facilitating mucosal attachment.
  • Surface/envelope antigens (antigenele de suprafață K), which confer resistance to host phagocytosis and complement-mediated lysis.
• Toxicity Factors (Factori de toxicitate):
  • Endotoxin: Lipopolysaccharide complex (endotoxina lipopolizaharidică) released upon cell lysis, precipitating vascular collapse and shock.
  • Hemolysins: Production of alpha ($\alpha$) and beta ($\beta$) hemolysins (hemolizinele alfa și beta).
  • Enterotoxins:
  • Thermostable enterotoxin (ST / TS): Antigenic low-molecular-weight protein.
  • Thermolabile enterotoxin (LT / TL): Non-antigenic (or weakly immunogenic in certain configurations) high-molecular-weight toxin causing hypersecretion of fluids and electrolytes.

Classification of Escherichia coli Pathotypes

Strains of E. coli are organized into six distinct pathotypes based on virulence factors, clinical patterns, and animal host specificity:

Epizootiology

• Host Receptivity and Age Limits:
  • Newborn calves aged $\le 10\,\text{days}$ represent the primary receptive population.
  • Clinical disease appears frequently in newborn calves, but generally spares calves up to $3\,\text{days}$ of age under normal colostral coverage, or concentrates heavily within the first week of life depending on passive immunity status.
• Predisposing Factors (Factori favorizanți):
  • Complete lack of colostrum ingestion (neconsumul de colostru); maternal colostrum is normally sterile at secretion.
  • Inadequate quality or insufficient quantity of ingested colostrum.
  • Technical feeding errors during artificial nursing or suckling.
  • Vitamin deficiencies in dams and calves, particularly Vitamins A and C.
  • Substandard microclimatic parameters (poor ventilation, chilling, excessive humidity, drafts).
  • Environmental stressors: Overcrowding, transport stress, and improper lotting/grouping (lotizări).
• Transmission Routes:
  • Exogenous Infection: Primarily via the digestive route; occasionally through the umbilical cord (ombilicală), respiratory tract, or transplacentally.
  • Endogenous Infection: Overgrowth and translocation of commensal intestinal flora under profound immunosuppression or metabolic stress.
• Sources of Infection:
  • Primary Sources:
  • Clinically diseased calves.
  • Asymptomatic carrier calves and adult livestock harboring pathogenic serotypes.
  • Cows suffering from coliform mastitis (mamite coliforme).
  • Other domestic species experiencing colibacillary enteritis.
  • Human fecal contamination.
  • Secondary Sources: Contaminated environmental vectors, including drinking water, soil, stable litter/bedding, barn utensils, and the unwashed hands of milking personnel.

Pathogenesis

The Septicemic Cascade

The invasive septicemic pathway follows seven sequential anatomical stages:

1. Digestive Penetration: Ingestion of pathogenic E. coli through contaminated colostrum, milk, or environment.
2. Ileal Multiplication: Primary colonization and massive bacterial multiplication localized in the ileum (the terminal segment of the small intestine).
3. Anterior Extension: Cranial spread toward the jejunum and duodenum, precipitating acute enteritis.
4. Mesenteric Lymph Nodes: Penetration of the intestinal mucosal barrier and invasion into the mesenteric lymph nodes (limfonodurile mezenterice).
5. Lymphatic Systemic Channels: Entry into the efferent mesenteric lymphatic vessels and thoracic duct.
6. Blood Dissemination: Ingress into circulating blood and secondary colonization of parenchymal organs.
7. Generalized Septicemia: Bacterial proliferation and widespread endotoxin liberation producing terminal septicemia (septicemie).

Intestinal Pathogenic Mechanism

• Adhesion and Colonization: Bacterial fimbriae and adhesins attach firmly to brush-border receptors on intestinal epithelial cells, preventing mechanical clearance by peristalsis.
• Toxin Release and Fluid Loss: Proliferation and production of enterotoxins trigger intracellular signaling cascades (such as cyclic nucleotide accumulation), leading to massive hypersecretion of water and electrolytes into the lumen and watery diarrhea.
• Invasive Strains with "Y" Fixation Factors:
  • Strains carrying specialized fixation factors directly invade enterocytes, multiply intracellularly, and trigger cell lysis.
  • Biphasic Clinical Progression: Initiates as profuse watery diarrhea and progresses into destructive, necrotizing hemorrhagic-ulcerative colitis (colită hemoragico-ulcerativă).

Clinical Signs and Evolution

• Incubation Period: Typically $12\text{--}24\,\text{hours}$, with an extreme range spanning from a few hours up to $24\,\text{hours}$.

Peracute / Hyperacute Form (Colisepticemia)

• Occurs predominantly in neonatal calves up to $5\,\text{days}$ of age that received insufficient or poor-quality colostrum.
• Characterized by profound systemic distress, hypothermia, recumbency, and coma.
• Diarrhea develops with distinctive whitish-yellowish feces (fecale alb-gălbui).
• Rapidly fatal, with death occurring within a few hours of clinical onset.

Acute Form (Enterotoxiemia colibacilară)

• Onset: Marked hyperthermia (fever), severe mental dullness and depression (abatere), and total inappetence. Calves exhibit tenesmus, abdominal colic, tympany/meteorism, and acute abdominal pain on palpation.
• Enteric Phase (After $24\text{--}48\,\text{hours}$):
  • Profuse diarrhea featuring yellowish, frothy, fetid stools.
  • Feces subsequently transition to a grayish hue and frequently become blood-streaked or frankly hemorrhagic (sanguinolente).

• Systemic Deterioration: Pale visible mucous membranes, dry lusterless hair coat, complete loss of dermal elasticity (severe cutaneous turgor deficit), and involuntary, continuous fecal leakage.
• Mortality: Death supervenes after $2\text{--}3\,\text{days}$ in $70\text{--}80\%$ of affected animals.

Subacute Form (Enterita colibacilară)

• Develops typically during the first $1\text{--}2\,\text{weeks}$ of life.
• Presents with a subfebrile state, mild to moderate depression, reduced milk intake, and persistent diarrhea.
• Produces progressive wasting, cachexia, and dehydration.
• Lethality reaches $70\text{--}80\%$ after several days of clinical course; surviving animals remain chronically emaciated, unthrifty, and severely stunted in growth.

Chronic Form

• Follows protracted subacute infections or partial immune containment.
• Dominated by localized organ lesions: Chronic catarrhal or purulent bronchopneumonia, arthritis, polyarthritis, and omphalophlebitis (omfaloflebite).
• Terminal phase includes central nervous deficits and hypothermia prior to death.

Anatomopathological and Histological Findings

Gross Pathological Lesions

• General Carcass Presentation: Dehydrated, cachectic carcasses soiled with liquid feces around the perineum, tail, and hocks; systemic lesions consistent with catarrhal-hemorrhagic enteritis.
• Septicemic Form: Widespread vascular injury, petechiae, ecchymoses, and suffusions on the epicardium, endocardium, hepatic capsule, and synovial membranes; pleural petechiation is less frequent.
• Acute Form:
  • Extensive petechial hemorrhages and suffusions.
  • Acute congestive and catarrhal lesions involving the abomasum (cheag) and small intestine.
  • Gaseous distension of the intestinal loops.
  • Markedly enlarged, edematous, and hemorrhagic mesenteric lymph nodes.
  • Degenerative changes (cloudy swelling, fatty degeneration) in the liver, myocardium, and renal parenchyma.
• Subacute and Chronic Forms:
  • Enteritis accompanied by necrotic mucosal foci.
  • Embolic focal nephritis, classically recognized as "white spotted kidney" (rinichi cu pete albe).
  • Chronic fibrinous or purulent arthritis, serofibrinous pleural and pericardial effusions, chronic pneumonia, and infected umbilical remnants (omphalophlebitis).

Histopathological Lesions

• Parenchymal Organs: Extensive microvascular bacterial emboli and intravascular thrombi dense with bacterial aggregates.
• Renal Parenchyma: The "white spotted kidney" is histologically identified as chronic multifocal interstitial lymphoplasmacytic nephritis (nefrită limfoplasmocitară).
• Central Nervous System: Fibrinopurulent leptomeningitis (meningite fibrinopurulente), focal areas of encephalomalacia, necrotizing vasculitis, and parenchymal microabscesses.
• Joint Synovia: Acute polyarthritis shows fibrinopurulent exudation, transitioning to lymphoplasmacytic infiltration in subacute and chronic courses.

Diagnosis

Laboratory Isolation and Identification

Definitive confirmation requires microbiological isolation, serological typing, and pathogenicity assessment:

• Bacterial Isolation: Samples harvested from bone marrow, heart blood, brain tissue, and mesenteric lymph nodes. Recovery of E. coli in pure culture from systemic organs confirms generalized colisepticemia.
• Serotyping: Performed via tube agglutination tests (both rapid and slow incubation methods) utilizing standardized polyvalent and monovalent reference antisera.
• Pathogenicity Testing: Evaluated in vivo through bacterial inoculation into ligated intestinal loops (segmente izolate ligaturate de intestin) in live rabbits.

Biological, Immunological, and Genetic Assays

• Enterotoxin Detection: Differentiation of heat-stable (ST) and heat-labile (LT) toxins via biological infant mouse assays or enzyme-linked immunosorbent assay (ELISA).
• Adhesin Identification: Slide agglutination tests (aglutinare pe lamă) using specific anti-fimbrial sera.
• Genetic and Cytotoxicity Assays:
  • Enterotoxin profiling by inoculation into ligated intestinal loops of mice or calves.
  • Verotoxins (VT1): Demonstration of cytopathogenic effect on permissive cell cultures, validated by specific seroneutralization.
  • Cytotoxic Necrotizing Factors (CNF): Laboratory animal inoculations, multinucleation assays on tissue culture, and specific ELISA testing for CNF1.

Differential Diagnosis and Prognosis

• Differential Diagnoses:
  • Salmonellosis (Salmoneloza)
  • Streptococcal septicemia (Streptococia)
  • Anaerobic enterotoxemia (Enterotoxiemia anaerobă, Clostridium perfringens)
  • Viral enteritides (Rotavirus and Coronavirus infections)
  • Coccidiosis (Coccidioza)
• Prognosis: Highly unfavorable to grave (grav), particularly in peracute colisepticemia and advanced enterotoxemia.

Prophylaxis

General Zootechnical Prophylaxis

• Dry Period Management: Implementation of an adequate dry period (repaus mamar) for pregnant cows adhering strictly to established zootechnical standards.
• Maternal Nutrition: Elimination of ensiled feeds (silage) from the diet during the final $2\text{--}3\,\text{months}$ of gestation, replacing them with high-quality meadow hay.
• Parturition Management: Immediate and thorough disinfection of the neonatal umbilical stump.
• Colostral Management: Compulsory feeding of $2\text{--}3\,\text{liters}$ of clean, high-titer colostrum, administered in fractionated doses within the critical first $5\text{--}6\,\text{hours}$ postpartum.
• Maternal Vitaminization: Parenteral administration of Vitamins A and C to late-gestation cows.
• Neonatal Vitaminization: Intramuscular or subcutaneous administration of Vitamin A to newborn calves at a dose of $300{,}000\,\text{IU}$, repeated at an interval of $3\text{--}4\,\text{days}$.
• Hygiene of Feeding Utensils: Maintenance of strict asepsis for nursing buckets, nipples, and mixing containers.

Specific Immunoprophylaxis

• Vaccination of Pregnant Dams:
  • Inoculation with commercial bacterins containing pathogenic calf serotypes, or herd-specific autovaccines generated from farm isolates, ensuring maternal antibodies are concentrated in colostrum.
  • Acetone-Inactivated Bivalent Vaccine (Vaccinul mixt acetonat antisalmonelic-anticolibacilar):
  • Injected subcutaneously at the tail fold (pliul cozii) during months $6\text{--}8$ of pregnancy.
  • Dose: $5\,\text{ml}$, boostered $21\text{--}30\,\text{days}$ later.
  • Protects the calf via passive colostral transfer for approximately $20\text{--}30\,\text{days}$.
• Recombinant and Subunit Vaccines: Modern genetic subunit vaccines containing purified fimbrial adhesins and toxoids (inactivated enterotoxins and cytotoxins).
• Polyvalent Formulations: Combined vaccines providing simultaneous protection against enterotoxigenic E. coli and enteric viral pathogens (Rotavirus and Coronavirus).

Therapeutic Control and Management

Therapeutic Objectives

1. Rapid vascular and interstitial rehydration.
2. Correction of systemic metabolic acidosis and electrolyte imbalances.
3. Arrest of mucosal inflammation and hypersecretory diarrhea.

Etiotropic Treatment

• Specific Serotherapy: Immediate administration of specific anti-colibacillary hyperimmune serum matching the incriminated farm serotype.
• Antimicrobial Therapy:
  • Parenteral and oral administration of broad-spectrum antibiotics (amoxicillin or oxytetracycline) combined with potentiated sulfonamides.
  • Isolates demonstrate widespread susceptibility to chloramphenicol, tetracycline, polymyxin, and systemic sulfonamides, notably sulfathiazole (sulfatiazol) and sulfamethazine (sulfametazină).

Dietary and Symptomatic Regimen

• Dietary Restriction: Complete withdrawal of whole milk for the first $1\text{--}2\,\text{days}$, placing the calf on a strict hydric diet.
• Gradual Nutritional Reintroduction: Progressive reintroduction of colostrum or milk diluted in herbal decoctions (peppermint, chamomile, and hay-flower infusions).
• Intestinal Protectants: Oral administration of mucosal adsorbents, astringents, antidiarrheal compounds, and flaxseed mucilage (mucilagiu de sămânță de in).
• Fluid and Electrolyte Resuscitation: Intravenous and oral rehydration therapy utilizing balanced electrolyte concentrates, normal physiological saline ($0.9\%\,\text{NaCl}$), and isotonic glucose solutions.
• Supportive Therapy:
  • High-dose multivitamin protocols containing Vitamins A, D, E, $B_{12}$, and C.
  • Cardiovascular and central nervous analeptic support (caffeine).